Product Information
IMIPRAMINE HCL 50 MG TABLET is a generic product labeled by Strides Pharma Inc., priced at $0.1240 per EA under NDC 64380017102. Its NADAC has been published 208 times since Jul 6, 2022.
Strength
50 mg/1
Manufacturer
Strides Pharma Inc.NDC
64380017102
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
IMIPRAMINE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA088276On Market Since
4/11/2022
Pharmacological Classes
Price Statistics
The NADAC for IMIPRAMINE HCL 50 MG TABLET has been published 208 times since Jul 6, 2022, and over the history we have for it it has declined 27.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1240 per EA |
|---|---|
| All-time high | $0.1716 (Jul 13, 2022) |
| All-time low | $0.0932 (Nov 20, 2024) |
| 52-week high | $0.1685 |
| 52-week low | $0.1240 |
| Median price | $0.1316 |
| Average price | $0.1318 |
| Largest weekly change | +30.3% (Nov 22, 2023) |
| Weeks tracked | 208 |
| Tracking since | Jul 6, 2022 |
Generic Alternatives
The matcher finds 3 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 3 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of IMIPRAMINE HCL 50 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for IMIPRAMINE HCL 50 MG TABLET, manufactured by Strides Pharma Inc., is $0.1240 per EA (NDC 64380017102), effective Jun 24, 2026.
How has the price of IMIPRAMINE HCL 50 MG TABLET changed over time?
Over the history we have for it, the NADAC for IMIPRAMINE HCL 50 MG TABLET has declined 27.8%. It has been tracked across 208 weekly CMS publications since Jul 6, 2022.
What are the highest and lowest recorded NADAC prices for IMIPRAMINE HCL 50 MG TABLET?
Since Jul 6, 2022, the NADAC for IMIPRAMINE HCL 50 MG TABLET has ranged from a low of $0.0932 (Nov 20, 2024) to a high of $0.1716 (Jul 13, 2022), with a median of $0.1316 per EA.
Are there cheaper alternatives to IMIPRAMINE HCL 50 MG TABLET?
3 NADAC-published products share the same active ingredient, strength, and dosage form as IMIPRAMINE HCL 50 MG TABLET, but none are currently priced below it.
Who manufactures IMIPRAMINE HCL 50 MG TABLET?
IMIPRAMINE HCL 50 MG TABLET (NDC 64380017102) is labeled by Strides Pharma Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification